hina Medical Technologies Inc., a leading China-based advanced in-vitro diagnostic (IVD) company, announced that its wholly-owned subsidiary Beijing Yuande Bio-Medical Engineering Co., Ltd. (Beijing Yuande) has passed the examination by the relevant government authorities and renewed its high and new technology enterprise status for another three year period from January 2011 to December 2013. With this status, Beijing Yuande is qualified for a preferential corporate income tax rate of 15 per cent, which is lower than the statutory corporate income tax rate of 25 per cent, as well as other government incentives for high and new technology enterprises.
China Medical Technologies, Inc. is a leading China-based advanced IVD company using molecular diagnostic technologies including Fluorescent in situ Hybridization (FISH) and Surface Plasmon Resonance (SPR) and an immunodiagnostic technology, Enhanced Chemiluminescence Immunoassay (ECLIA), to develop, manufacture and distribute diagnostic products used for the detection of various cancers, diseases and disorders as well as companion diagnostic tests for targeted cancer drugs.
Source:Pharmabiz
No comments:
Post a Comment